Ann: Refinancing of Convertible Security Agreement, page-2

I read this part several times and I am just as bewildered as to what MXC is actually produces and what direction of drug development they are chasing.

They don't have any substance - and no firm goals it would appear.

Alos note that they have morphed into a European phama company - no longer an Australian pharma company.

About MGC Pharma

MGC Pharmaceuticals Ltd (LSE: MXC, ASX: MXC) is a prominent European pharmaceutical company with a
strong commitment to creating accessible and ethically produced cutting-edge medicines. Our approach
combines in-house research with innovative technologies, all aimed at discovering and producing
treatments for currently unmet medical conditions.
The company's founders and executives are distinguished figures in the global pharmaceutical industry. Our central business
strategy revolves around the development and supply of innovative medicines, responding to the increasing demand in the
medical markets of Europe, North America, and Australasia.
MGC Pharma maintains a robust development pipeline that addresses two prevalent medical conditions, with additional
products currently in the developmental stages. We've established strategic partnerships with renowned institutions and
academia, fostering the optimization of our medicines' development. These medicines are produced in our EU-GMP Certified
manufacturing facilities, ensuring the highest quality standards.
With a growing patient base in key regions like the USA, UK, Australia, and Ireland, MGC Pharma has also built a global
distribution network through a wide-reaching group of commercial partners. This extensive network places us in a prime
position to supply the global market effectively.